Skip to main content
Premium Trial:

Request an Annual Quote

Chris Hodkinson, Marc van der Schee, and Hamilton Scanlon

Owlstone Medical has appointed Chris Hodkinson as vice president of business development, Marc van der Schee as lead clinical research scientist, and Hamilton Scanlon as vice president of manufacturing. Hodkinson joins Owlstone from Abcodia, which he co-founded and where he served as director and chief operating officer. Van der Schee joins the company with 10 years of experience in the field of volatile biomarker research. Scanlon joins Owlstone with over 30 years of experience in product development. He has worked at start-up companies and PLCs, and has been responsible for setting up manufacturing facilities within China, Italy, and the UK.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.